Drug manufacturers and anti-doping agencies

Nowadays many pharmaceutical companies are ready to collaborate with anti-doping officials in their war on application of prohibited drugs in sports. It sounds strange but it is the reality. In fact, if you review the fate of EPO, you can comprehend why drug manufacturers agree to support efforts of anti-doping officials. EPO is really an efficient remedy for treatment of anemia. Numerous individuals with anemia that have applied EPO have been treated. But what do you think while hearing about this preparation? Almost each individual associates this remedy only with doping in sports. This product has been abused by the American cyclist Lance Armstrong that has cheated the whole world. Thus, EPO is associated just with lying, disgrace, etc. Looking at this case, drug manufacturers try to “defend” their medications from the similar fate. That’s why they work together with anti-doping officers.
Although certain drug manufacturers began to cooperate with anti-doping officials long ago, sometimes there were certain problems between them. Anti-doping officers criticized certain pharmaceutical companies for their connections with doping.
Today relations between anti-doping agencies and drug manufacturers are closer. Pharmaceutical companies share detailed information about new drugs with anti-doping officials. It is precious information for development of detection tests for these medications. While anti-doping officials learn how medications are manufactured, how they pass into body, how they work in the body, they can elaborate more efficient tests for these medications.
For example, the pharmaceutical company Roche that developed the medicine CERA helped anti-doping agencies to develop a detection test for it. Later other companies followed the example of Roche. The company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during the 2012 Olympics.
While relations between anti-doping agencies and huge drug manufacturers become stronger, smaller drug manufacturers started to cooperate with anti-doping agencies too. While earlier pharmaceutical companies haven’t wanted to discuss about their links to anti-doping officers openly, now they don’t fear to announce about this condition.